DNAPrint Genomics, Inc.
DNAG · OTC
9/30/2007 | 6/30/2007 | 3/31/2007 | 12/31/2006 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$1,881 | -$1,697 | $2,888 | -$3,861 |
| Dep. & Amort. | $156 | $179 | $219 | $261 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$98 | -$51 | -$61 | $1,217 |
| Other Non-Cash | $462 | $361 | -$4,293 | $2,059 |
| Operating Cash Flow | -$1,362 | -$1,208 | -$1,247 | -$324 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | $0 | -$2 | -$161 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $2,006 | $1,951 | $0 |
| Other Inv. Act. | $1,351 | $0 | $0 | $555 |
| Investing Cash Flow | $1,350 | $2,006 | $1,949 | $393 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$330 | -$712 | -$1,635 | $94 |
| Stock Issued | -$8 | $150 | $607 | $312 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $0 |
| Financing Cash Flow | -$338 | -$562 | -$1,028 | $405 |
| Forex Effect | -$23 | $2 | $1 | $10 |
| Net Chg. in Cash | -$374 | $239 | -$325 | $484 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $508 | $269 | $595 | $111 |
| End Cash | $134 | $508 | $269 | $595 |
| Free Cash Flow | -$1,363 | -$1,208 | -$1,249 | -$486 |